BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16640340)

  • 1. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
    Singh C; Malik H; Puri SK
    J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bis- and tris-1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice.
    Singh C; Verma VP; Naikade NK; Singh AS; Hassam M; Puri SK
    J Med Chem; 2008 Dec; 51(23):7581-92. PubMed ID: 19006381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-(4'-Aryloxy-phenyl)vinyl-1,2,4-trioxanes: a new series of orally active peroxides effective against multidrug-resistant Plasmodium yoelii in Swiss mice.
    Singh C; Verma VP; Naikade NK; Singh AS; Hassam M; Puri SK
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4459-63. PubMed ID: 20598529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria.
    Singh C; Kanchan R; Sharma U; Puri SK
    J Med Chem; 2007 Feb; 50(3):521-7. PubMed ID: 17266204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally active antimalarials: synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice.
    Singh C; Sharma U; Saxena G; Puri SK
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4097-101. PubMed ID: 17548195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antimalarial assessment of a new series of orally active amino-functionalized spiro 1,2,4-trioxanes.
    Singh C; Hassam M; Naikade NK; Verma VP; Singh AS; Puri SK
    J Med Chem; 2010 Nov; 53(21):7587-98. PubMed ID: 20936847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New orally active derivatives of artemisinin with high efficacy against multidrug-resistant malaria in mice.
    Singh C; Chaudhary S; Puri SK
    J Med Chem; 2006 Nov; 49(24):7227-33. PubMed ID: 17125275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New orally active spiro 1,2,4-trioxanes with high antimalarial potency.
    Singh C; Malik H; Puri SK
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4484-7. PubMed ID: 16105737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-(1-Naphthalen-2-yl-vinyl)-6,7,10-trioxaspiro (4.5) decane, a new 1,2,4-trioxane effective against rodent and simian malaria.
    Singh C; Kanchan R; Srivastava D; Puri SK
    Bioorg Med Chem Lett; 2006 Feb; 16(3):584-6. PubMed ID: 16275088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally active 1,2,4-trioxepanes: synthesis and antimalarial activity of a series of 7-arylvinyl-1,2,4-trioxepanes against multidrug-resistant Plasmodium yoelii in Swiss mice.
    Singh C; Pandey S; Sharma M; Puri SK
    Bioorg Med Chem; 2008 Feb; 16(4):1816-21. PubMed ID: 18054238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid-based 1,2,4-trioxanes: synthesis and antimalarial assessment.
    Singh C; Hassam M; Verma VP; Singh AS; Naikade NK; Puri SK; Maulik PR; Kant R
    J Med Chem; 2012 Dec; 55(23):10662-73. PubMed ID: 23163291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of new 6-alkylvinyl/arylalkylvinyl substituted 1,2,4-trioxanes active against multidrug-resistant malaria in mice.
    Singh C; Gupta N; Puri SK
    Bioorg Med Chem; 2004 Nov; 12(21):5553-62. PubMed ID: 15465332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linker-based hemisuccinate derivatives of artemisinin: synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice.
    Singh C; Kanchan R; Chaudhary S; Puri SK
    J Med Chem; 2012 Feb; 55(3):1117-26. PubMed ID: 22216834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimalarial activity of a new series of trioxaquines.
    Singh C; Malik H; Puri SK
    Bioorg Med Chem; 2004 Mar; 12(5):1177-82. PubMed ID: 14980628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel 1,2,4-trioxanes and antimalarial evaluation against multidrug-resistant Plasmodium yoelii nigeriensis.
    Shukla M; Hassam M; Kumar Yadav D; Sharma S; Singh C; Puri SK; Shrivastava R; Prakash Verma V
    Bioorg Med Chem Lett; 2021 Oct; 49():128305. PubMed ID: 34365007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New orally active diphenylmethyl-based ester analogues of dihydroartemisinin: Synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice.
    Chaudhary S; Naikade NK; Tiwari MK; Yadav L; Shyamlal BRK; Puri SK
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1536-1541. PubMed ID: 26898813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally active amino functionalized antimalarial 1,2,4-trioxanes.
    Singh C; Malik H; Puri SK
    Bioorg Med Chem Lett; 2004 Jan; 14(2):459-62. PubMed ID: 14698181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel naphthyl based 1,2,4-trioxanes: Synthesis and in vivo efficacy in the Plasmodium yoelii nigeriensis in Swiss mice.
    Karnatak M; Hassam M; Vanangamudi M; Sharma S; Kumar Yadav D; Singh C; Puri SK; Rawat V; Prakash Verma V
    Bioorg Med Chem Lett; 2021 Nov; 51():128372. PubMed ID: 34547418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
    Awasthi A; Dutta GP; Bhakuni V; Tripathi R
    Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New functionalized 1,2,4-trioxepanes: synthesis and antimalarial activity against multi-drug resistant P. yoelii in mice.
    Singh C; Pandey S; Kushwaha AK; Puri SK
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5190-3. PubMed ID: 18789862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.